chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstrual disorder, Muscle tightness, Myalgia, Peripheral coldness, Tremor
Clinical narrative: she cannot pee; she missed her menstrual cycle for the entire month of June; autoimmune deficiency; her hands have been freezing up; Muscle pain; lymph nodes are swollen; she shakes really bad; she cannot swallow/ can barely eat; she gets weaker; She is scared every night; she can barely have a bowel movement; Her muscles are tight; felt like it was shutting her body down; she was so sad; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 26Apr2021 (Batch/Lot number was not reported) at the age of 30 years as single dose for covid-19 immunisation. There were no medical history or concomitant medications. Historical vaccine included the first dose of BNT162B2 for covid-19 immunisation. Patient stated she was having bad side effects and didn't know what to do. She felt like it was shutting her body down. Since the second dose she missed her menstrual cycle for the entire month of June. She had been to the hospital 15-20 times. Said her hands had been freezing up, she had muscle pain, lymph nodes are swollen, she shaked really bad, she cannot swallow, she cannot pee. She kept going to the hospital; stated she was scared for her life and kept going to the emergency room but cannot get an answer. Patient said she was healthy before the vaccine. They told her she had an autoimmune deficiency after the shot. Stated she had never had anything autoimmune before. They tested her for was though and all the tests were negative. Said they did a CT scan of her stomach and tested her for everything. Stated she got weaker everyday. It just kept getting worse and she didn't know what to do. It had worsened gradually over time. Stated she felt there was no guarantee that she would live. She was scared every night. Her muscles were tight, she was in and out of the emergency room. Said the emergency room kept sending her away. Stated she can barely have a bowel movement or eat. Stated this all happened after the vaccine. She was a perfectly healthy 30 year old woman before the vaccine. The vaccine was ruining her life. She had gradually gotten worse over time. Everyday she felt worse and she was so sad. Patient had mentioned testing for autoimmune deficiency that was negative earlier in the call. She had also mentioned a CT Scan of her stomach and being tested for everything. No results provided by the caller. Outcome of events were unknown.   Information about lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary retention
Clinical narrative: she cannot pee; she missed her menstrual cycle for the entire month of June; autoimmune deficiency; her hands have been freezing up; Muscle pain; lymph nodes are swollen; she shakes really bad; she cannot swallow/ can barely eat; she gets weaker; She is scared every night; she can barely have a bowel movement; Her muscles are tight; felt like it was shutting her body down; she was so sad; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 26Apr2021 (Batch/Lot number was not reported) at the age of 30 years as single dose for covid-19 immunisation. There were no medical history or concomitant medications. Historical vaccine included the first dose of BNT162B2 for covid-19 immunisation. Patient stated she was having bad side effects and didn't know what to do. She felt like it was shutting her body down. Since the second dose she missed her menstrual cycle for the entire month of June. She had been to the hospital 15-20 times. Said her hands had been freezing up, she had muscle pain, lymph nodes are swollen, she shaked really bad, she cannot swallow, she cannot pee. She kept going to the hospital; stated she was scared for her life and kept going to the emergency room but cannot get an answer. Patient said she was healthy before the vaccine. They told her she had an autoimmune deficiency after the shot. Stated she had never had anything autoimmune before. They tested her for was though and all the tests were negative. Said they did a CT scan of her stomach and tested her for everything. Stated she got weaker everyday. It just kept getting worse and she didn't know what to do. It had worsened gradually over time. Stated she felt there was no guarantee that she would live. She was scared every night. Her muscles were tight, she was in and out of the emergency room. Said the emergency room kept sending her away. Stated she can barely have a bowel movement or eat. Stated this all happened after the vaccine. She was a perfectly healthy 30 year old woman before the vaccine. The vaccine was ruining her life. She had gradually gotten worse over time. Everyday she felt worse and she was so sad. Patient had mentioned testing for autoimmune deficiency that was negative earlier in the call. She had also mentioned a CT Scan of her stomach and being tested for everything. No results provided by the caller. Outcome of events were unknown.   Information about lot/batch number has been requested.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: 1st dose pfizer vaccine was given to patient on 07/06/2021. We found out on 07/09/2021 vaccine was stored outside the recommended 31 day expiration window.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dyspnoea, Pain, Pain in extremity
Clinical narrative: Back pain, shortness of breathe, chills, fatigue, unable to lay down and breathe  Filling up with fluids
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chills, Dyspnoea, Fatigue, Fluid retention
Clinical narrative: Back pain, shortness of breathe, chills, fatigue, unable to lay down and breathe  Filling up with fluids
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: CSF protein increased, CSF red blood cell count, Guillain-Barre syndrome, Lumbar puncture, Magnetic resonance imaging spinal abnormal
Clinical narrative: guillain barre syndrome
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging thoracic abnormal
Clinical narrative: guillain barre syndrome
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: guillain barre syndrome
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Crying, Gait inability, Guillain-Barre syndrome, Impaired work ability, Pain
Clinical narrative: guillain barre syndrome
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paralysis
Clinical narrative: guillain barre syndrome
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Peripheral swelling, Pyrexia
Clinical narrative: Redness, swelling and pain in left arm Doxycycline 100 mg Po BID x 10 days
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: Redness, swelling and pain in left arm Doxycycline 100 mg Po BID x 10 days
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: Error: Improper Storage (temperature)-
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (temperature)-
Sex: F
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: No further information is available; a patient received an expired RECOMBIVAX; This spontaneous report was received from a pharmacist referring to a female patient of unknown age. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.   On 03-JUL-2021, the patient was vaccinated with an expired hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (0.5 ml, once, lot # R028384, expiration date 08-JUN-2021; strength and route of administration were not reported) for prophylaxis (expired product administered). No further information was available (no adverse event). No product quality complaint (PQC) was reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Fever; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER8730), via an unspecified route of administration in the left arm on 26Mar2021 at 15:45 (at the age of 66-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, allergies and gout. The patient was allergic to penicillin, bees, and some blood pressure medicines. Concomitant medications included benazepril hcl (MANUFACTURER UNKNOWN) 40 (unspecified units) and allopurinol (MANUFACTURER UNKNOWN) 100 (unspecified units); both from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER6206), via unspecified route of administration in the left arm on 05Mar2021 at 16:45 (at the age of 66-years-old), as a single dose for COVID-19 immunisation and naproxen sodium (ALEVE) on unknown date for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 27Mar2021 at 04:15, the patient experienced fever, chills and severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. The clinical outcome of the events fever, chills and severe headache was recovered on an unspecified date in Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Swollen lymph node in left neck base, left and right armpit; discomfort and second day is the same with arm pit discomfort; This is a spontaneous report received from a contactable consumer, the patient. A 58- years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7533) via an unspecified route of administration administrated in the left arm on 25Mar2021 at 13:00(at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to sulpha drugs. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) from an unknown date and for an unknown indication received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198) via an unspecified route of administration administrated in the left arm on 04Mar2021 at 13:00 as a single dose for COVID-19 immunisation. The patient was also allergic to epinephrine and codeine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 26Mar2021 at 16:00 the day after the vaccine the patient experienced lymph nodes in left neck base swelled and were very uncomfortable. Then lymph nodes in left armpit swelled and caused discomfort, second day was the same with right armpit discomfort. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient underwent lab tests which included nasal swab on 20Mar2021 and tested negative post vaccination. The clinical outcome of the event swollen lymph node and discomfort was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Throat tightness
Clinical narrative: my lips were numb; throat was tight; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27Mar2021 at 12:30 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included gabapentin (GRALISE) 600 mg at bedtime. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 27Mar2021, 30 mins (at 13:00) after vaccination, the patient experienced numbness in lips and throat tightness. The patient had not received any treatment for the event. The adverse event had not resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lips numb and throat tight was recovered on an unspecified date.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cognitive disorder
Clinical narrative: I experienced and corrected 3cognitive impairments; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via unspecified route of administration on right arm on 03Mar2021 at 09:45 (at the age of 59-years-old) as single dose for COVID-19 immunisation. Medical history was reported as animal dander, pollen allergies and sulfa drugs. The concomitant medications included fexofenadine hydrochloride (ALLEGRA), mometasone furoate (FLONASE), fisetin (MANUFACTURER UNKNOWN), ascorbic acid, calcium, minerals nos, retinol, tocopheryl acetate, Vitamin b nos, Vitamins nos, zinc (CENTRUM SILVER) and vit d nos (MANUFACTURER UNKNOWN) for an unknown indication on unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW6199) via unspecified route of administration in left arm on unknown date as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 27Mar2021 the patient experienced and corrected 3 cognitive impairments shortly after waking up in the morning, while executing his morning coffee routine, in the space of 30 minutes he made 3 mistakes as follows. He poured the unground coffee beans into the coffee filter instead of the grinder which he had never done before. He put the plastic wrapper for the coffee packet into the yard waste instead of the trash which he has never done before. He lost his coffee cup and was unable to find it which he rarely does. The patient reported that all these happens less than once a year and he wish to clarify that he is not joking hence he had been doing the exact same things every morning for decades. The patient reported that he cannot assign this to anything other than the 2nd vaccine shot because he is isolated and he works from home, he also stated that his life has been quite routine and the only 'puncture' to his equilibrium has been his 2 trips to the hospital for the vaccine and he reported in the hope of helping out. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatments for the adverse event. The clinical outcomes of the events were resolved on an unspecified date in Mar2021 at the time of this report.   No follow-up attempts are needed. No further information expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Headache, Tinnitus
Clinical narrative: severe left sided headache near eye; burning sensation throughout my body; severe ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730), via an unspecified route of administration in the left arm on 25Mar2021 at 09:30 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included obesity, vertigo, IBS and SVT. The patient did not take any concomitant medications within two weeks of vaccination. The patient was allergic to latex and cayenne pepper. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 09:35 (within first 5 minutes post-vaccine), patient experienced burning sensation throughout body which resolved; severe left sided headache near eye on 25Mar2021 at 09:45; and 3 days later, on an unknown date in Mar2021 severe ringing in ears. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events burning sensation was not resolved (also reported as resolved on an unknown date), while of headache and ringing in ears was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Feeling abnormal, Musculoskeletal stiffness
Clinical narrative: Fever; chills; muscle and joint pain throughout body; ,muscle and joint pain throughout body,; weakness.; stiffness; brain fog; nausea.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727), via an unspecified route of administration in the left arm on 26Mar2021 at 10:15 hours (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patients medical history included food allergy and COVID-19. Concomitant medications included pure encapsulations pure pack (supplement). The patient was allergic to nightshades (food). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 26March2021, at 21:00 hours patient experienced fever, chills, muscle and joint pain throughout body, weakness, stiffness, brain fog and nausea. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever, chills, muscle and joint pain throughout body, weakness, stiffness, brain fog, nausea was recovered on unknown date in March2021 at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Fever; chills; muscle and joint pain throughout body; ,muscle and joint pain throughout body,; weakness.; stiffness; brain fog; nausea.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727), via an unspecified route of administration in the left arm on 26Mar2021 at 10:15 hours (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patients medical history included food allergy and COVID-19. Concomitant medications included pure encapsulations pure pack (supplement). The patient was allergic to nightshades (food). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 26March2021, at 21:00 hours patient experienced fever, chills, muscle and joint pain throughout body, weakness, stiffness, brain fog and nausea. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever, chills, muscle and joint pain throughout body, weakness, stiffness, brain fog, nausea was recovered on unknown date in March2021 at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dysgeusia, Headache, Pain
Clinical narrative: Bitter taste when eating, as if sweet, salty is less sensitive; chills; Body ache; fever 101; bad headache.; Bitter taste when eating; This is a spontaneous report received from a contactable other health care professional, the patient. A 48-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via unspecified route of administration in the left arm on 25Mar2021 at 12:45 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma since unknown date. The patient did not receive any other medication within 2 weeks of vaccination. The patient had known allergies to sulfa (sulfonamide) drugs and bactrim. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 26Mar2021 at 15:00, the patient experienced bitter taste when eating, as if sweet, salty was less sensitive and all that is tasted in food was bitterness, still it happened three days after the shot. After 18 hours, the patient experienced chills, body aches, fever of 101 and bad head ache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the events bitter taste, taste altered, chills, general body pain, fever and headache were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Taste disorder
Clinical narrative: Bitter taste when eating, as if sweet, salty is less sensitive; chills; Body ache; fever 101; bad headache.; Bitter taste when eating; This is a spontaneous report received from a contactable other health care professional, the patient. A 48-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via unspecified route of administration in the left arm on 25Mar2021 at 12:45 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma since unknown date. The patient did not receive any other medication within 2 weeks of vaccination. The patient had known allergies to sulfa (sulfonamide) drugs and bactrim. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 26Mar2021 at 15:00, the patient experienced bitter taste when eating, as if sweet, salty was less sensitive and all that is tasted in food was bitterness, still it happened three days after the shot. After 18 hours, the patient experienced chills, body aches, fever of 101 and bad head ache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the events bitter taste, taste altered, chills, general body pain, fever and headache were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Headache, Pain in extremity
Clinical narrative: Salty bitter after taste by back of tongue; headache; sore arm; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6207), via an unspecified route of administration in the left arm on 27Mar2021 at 11:15 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. The medical history of the patient was reported as 'Yes'. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. The patient received unspecified medications within two weeks of COVID-19 vaccination. On 27Mar2021 at 11:15, the patient experienced salty bitter after taste by back of tongue, headache and sore arm. The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of salty bitter after taste by back of tongue, headache and sore arm was recovering at the time of this report.  No follow up attempts are possible. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Soreness at site of injection; headache; This is a spontaneous report from a non-contactable consumer. A 29-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration on 27Mar2021 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medication were not reported.  On an unspecified date in Mar2021, the patient experienced soreness at site of injection and headache. The patient did not receive any treatment for the reported events. The clinical outcome of the soreness at site of injection and headache were recovered on an unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension, Pain in extremity, Taste disorder, Vertigo
Clinical narrative: Taste rubber/vanilla milk; Vertigo prone sleeping; High blood pressure; Left arm sore; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en 6206) via an unspecified route of administration in the left arm on 06Mar2021 at 15:00 (at the age of 64-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder removed on 11Feb2021. The patient had no known allergies. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 07Mar2021 at 04:00, the patient experienced taste rubber/vanilla milk, vertigo prone sleeping, high blood pressure and left arm sore 5 days. Therapeutic measure was taken as result of event vertigo and included treatment with meclizine (MANUFACTURER UNKNOWN). The adverse events resulted in doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The clinical outcome of taste rubber/vanilla milk, vertigo prone sleeping, high blood pressure and left arm sore were resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever 101; chills; headache; ache; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid nodule (benign). The patient had known allergies to sulfa drugs and lamisil. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) started on an unknown date for thyroid medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed for COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 28Mar2021 at 00:00 (12 hours after the vaccination), the patient experienced fever 101 (unspecified unit), chills, ache and headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever 101, chills, ache and headache were resolving at the time of this report.   No follow up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: Significant nausea and diarrhea.; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 27Mar2021 at 11:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient did not have allergies to medications, food, or other products. Concomitant medications included unspecified statin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) both for an unknown indication and started from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 28Mar2021 at 00:00, the patient experienced significant nausea and diarrhea. The events had not resulted in the visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events nausea and diarrhea. The clinical outcomes of the events nausea and diarrhea were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Headache, Muscle fatigue
Clinical narrative: Cold sweats; chills; muscle fatigue; headache; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (at the age of 48-years-old) for COVID-19 immunisation. The patient had known allergy to guaifenesin. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the left arm on 05Mar2021 at 13:00 (at the age of 48-years-old) for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications received within two weeks of vaccination included vitamin D (MANUFACTURER UNKNOWN) and famotidine 20mg acid reducer (MANUFACTURER UNKNOWN). The patient experienced cold sweats, chills, muscle fatigue and headache on 27Mar2021 at 03:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of cold sweats, chills, muscle fatigue and headache were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia, Mobility decreased, Peripheral swelling, Swelling
Clinical narrative: pain at injection site; swelling at injection site; whole body swollen; my legs and arms were swollen; ankles, elbows, wrists, shoulders had less mobility.; numbness at hands; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 24Mar2021 at 10.15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included HIV and COVID-19 on May2020. Concomitant medications included abacavir sulfate, lamivudine, dolutegravir sodium, (TRIUMEQ), naproxen (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), hydroxyzine (MANUFACTURER UNKNOWN); all from unknown for unspecified indications. The patient previously took bioflavonoids on unknown date and experienced an food allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On the day of vaccination (24Mar2021), the patient experienced bit fatigued. Nothing bothersome. On 25Mar2021, the next morning, the patient woke up with a good deal of pain and swelling at the injection site. In addition, whole body was swollen, in particular the legs and arms were swollen, to the point that was much harder than usual to be ambulatory. The ankles, elbows, wrists, shoulders had less mobility and also had numbness at hands.  Thankfully, by mid-afternoon of the 25th, felt much better and much of the swelling had subsided. The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the fatigue, pain at injection site, swelling at injection site, swelling at whole body, legs and arms, decreased mobility of ankles, elbows, wrists, shoulders and numbness at hands were resolving.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: pain at injection site; swelling at injection site; whole body swollen; my legs and arms were swollen; ankles, elbows, wrists, shoulders had less mobility.; numbness at hands; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 24Mar2021 at 10.15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included HIV and COVID-19 on May2020. Concomitant medications included abacavir sulfate, lamivudine, dolutegravir sodium, (TRIUMEQ), naproxen (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), hydroxyzine (MANUFACTURER UNKNOWN); all from unknown for unspecified indications. The patient previously took bioflavonoids on unknown date and experienced an food allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On the day of vaccination (24Mar2021), the patient experienced bit fatigued. Nothing bothersome. On 25Mar2021, the next morning, the patient woke up with a good deal of pain and swelling at the injection site. In addition, whole body was swollen, in particular the legs and arms were swollen, to the point that was much harder than usual to be ambulatory. The ankles, elbows, wrists, shoulders had less mobility and also had numbness at hands.  Thankfully, by mid-afternoon of the 25th, felt much better and much of the swelling had subsided. The patient did not receive any treatment for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the fatigue, pain at injection site, swelling at injection site, swelling at whole body, legs and arms, decreased mobility of ankles, elbows, wrists, shoulders and numbness at hands were resolving.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Malaise
Clinical narrative: Severe headache/ back of head ached; neck ached; Nausea; fatigue; muscle pain; chills; swollen lymph nodes - left neck; generally feeling unwell; This is a spontaneous report from a contactable other health care professional, the patient. A 57-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via unspecified route of administration in the left arm on 26Mar2021 at 10:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as COVID-19 on unspecified date. The patient was allergic to aspirin and penicillin. Concomitant medications were reported as karma cleanse, hepata tox, heverts lymph detox and H, (MANUFACTURER UNKNOWN) for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. On 26Mar2021 at 11:30 patient experienced severe headache, back of head and neck ached, nausea, fatigue, muscle pain, chills, swollen lymph nodes of left neck and generally feeling unwell. The patient did not receive treatment for the reported events. On 21Jun2020, the patient had nasal Swab resulted positive, whereas on 03Aug2020 and 01Oct2020 it was negative, respectively. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of all the events severe headache, neck pain, nausea, fatigue, myalgia, chills, lymphadenopathy and malaise were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Neck pain, SARS-CoV-2 test
Clinical narrative: Severe headache/ back of head ached; neck ached; Nausea; fatigue; muscle pain; chills; swollen lymph nodes - left neck; generally feeling unwell; This is a spontaneous report from a contactable other health care professional, the patient. A 57-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via unspecified route of administration in the left arm on 26Mar2021 at 10:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as COVID-19 on unspecified date. The patient was allergic to aspirin and penicillin. Concomitant medications were reported as karma cleanse, hepata tox, heverts lymph detox and H, (MANUFACTURER UNKNOWN) for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. On 26Mar2021 at 11:30 patient experienced severe headache, back of head and neck ached, nausea, fatigue, muscle pain, chills, swollen lymph nodes of left neck and generally feeling unwell. The patient did not receive treatment for the reported events. On 21Jun2020, the patient had nasal Swab resulted positive, whereas on 03Aug2020 and 01Oct2020 it was negative, respectively. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of all the events severe headache, neck pain, nausea, fatigue, myalgia, chills, lymphadenopathy and malaise were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity, Vomiting
Clinical narrative: vomiting; dizzy headed; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non- pregnant female patient, received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on 26Mar2021 at 12:30 (at the age of 48-years-old) in left arm as a single dose for COVID-19 immunisation. Medical history included egg allergy. Concomitant medications included methylprednisolone (MANUFACTURER UNKNOWN) and caffeine; paracetamol(EXCEDRIN) all from unknown dates for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 27Mar2021 at 09:00, the patient experienced vomiting, dizzy headed and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of vomiting, dizziness and pain in arm were recovering at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Injection site is still red 10 days after first dose; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6207), via an unspecified route of administration in the left arm on 18Mar2021 at 09:00 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications included drospirenone; ethinylestradiol (LORYNA), vitamin B12 (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC), paracetamol (TYLENOL); all for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 since the vaccination. On 18Mar2021 at 10:00, one hour after vaccination, the patient experienced injection site redness which still exist 10 days after first dose. The patient did not receive any treatment for the event. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the vaccination site erythema was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Illness, Nasopharyngitis
Clinical narrative: Two months post final dose left arm became entirely numb; extremely ill; bad cold four days after the injection; This is a spontaneous report from a contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3246), via an unspecified route of administration in the left arm on 16Jan2021(at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included common variable immune deficiency. The patient was allergic to sulfa. The patient received other medications (unspecified) within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EK9231), via an unspecified route of administration in the left arm on 26Dec2020 (at the age of 29-years-old) as a single dose for COVID-19 immunisation and experienced injection soreness on an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Jan2021, the patient experienced the extreme illness and bad cold (four days after the injection). On 23Mar2021, 2 months after the second dose, the patient experienced the event entire left arm numbness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events illness, cold and numbness was unknown.   No follow-up attempts are needed. No further information is expected.